Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 70 references it cites were found in a registry or an index, and 4 are not checked yet; 18 of the 69 sources its claims cite were checked for support.

Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics

Open access

Abstract

Significance: Hypertrophic cardiomyopathy (HCM) is a common genetic heart disease and a leading cause of sudden cardiac death in young adults. HCM has been linked to mutations in genes encoding sarcomeric proteins, but how different mutations can result in a similar clinical phenotype is unknown. Analysis of surgical heart tissue samples from HCM patients with severe outflow track obstruction using high-resolution mass spectrometry–based top-down proteomics revealed a common pattern of altered sarcomeric proteoforms across HCM tissues compared to non-failing donor heart tissues. Our data suggest that common pathways are associated with clinical phenotypes in patients diagnosed with obstructive HCM, opening the door for the development of interventions that target the HCM phenotype rather than the individual sarcomeric gene mutation.

Verified 2026-10-05 · 4 references not checked yet

Overview

CoChat Summary

TL;DR

Top-down proteomics of human HCM septal myectomy and donor heart tissues revealed a complex sarcomeric proteoform landscape and convergent phosphorylation/isoform changes across different HCM genotypes. The findings suggest common PKA-related pathways and support targeting the obstructive HCM phenotype rather than individual sarcomeric mutations.

Key findings

  • In HCM tissues (n = 16) versus donor tissues (n = 16), total phosphorylation was significantly decreased for cTnI (HCM consistently below 0.6 mol Pi/mol protein vs. donor 0.7–2.0; P < 0.001), ENH2 (HCM below 0.3 vs. donor 0.4–1.1; P < 0.001), Tpm1.1 (23% decrease; P < 0.001), and MLC-2v (57% decrease; P < 0.001).
  • cTnT total phosphorylation increased by about 10% in HCM tissues compared with donor tissues (P < 0.05), while cTnT (aa 1 to 286) phosphorylation increased by 8% but was not significant.
  • cTnI and ENH2 phosphorylation were strongly linearly correlated across groups (R² = 0.9276); cTnI phosphorylation was localized to Ser22/23, ENH2 phosphorylation to Ser118, and PKA phosphorylated ENH2 in vitro.
  • Despite different HCM-causing mutations, the HCM tissues showed consistent sarcomeric proteoform alterations; Tpm3.12 was detected in eight HCM myectomy tissues but in none of the control samples, and MLC-1a percentage ranged from 0.7–11.3% in donor tissues and 1.1–13.9% in HCM tissues.

Methods

  • Sarcomeric proteins were extracted from human septal myectomy tissues from obstructive HCM patients (n = 16) and left ventricular tissue from nonfailing donor hearts (n = 16); 500 ng total sarcomeric protein per sample was analyzed by LC-MS, requiring 7–10 mg tissue and less than 3 h per sample.
  • Top-down MS used high-resolution LC-MS, with ultrahigh-resolution FTICR MS/MS and ECD/CAD for sequence characterization and PTM localization; proteoform relative abundance was calculated from peak intensities.
  • Statistical significance between Ctrl and HCM groups was assessed with a Wilcoxon rank sum test because not all data were normally distributed by Shapiro–Wilk test; significance was set at P < 0.05.

Limitations

  • The paper states that only surgical tissues from HCM patients with severe outflow tract obstruction undergoing septal myectomy were studied; early-stage/mild HCM is not represented, and it remains unclear whether the alterations are intrinsic to late-stage obstructive HCM or reflect obstructive physiology, so caution is needed in extrapolating to the entire HCM population.
  • The paper states that only a small subset of HCM genotypes was captured, so the convergence conclusion is limited to obstructive HCM patients with mutations in MYH7 or MYBPC3 as analyzed, independent of specific mutation type.
  • The text makes evident that low-abundance proteoforms (e.g., Tpm2.2, Tpm3.12, cypher-6, MLP, CRIP2, ALP-H) were difficult to quantify accurately, phosphorylation-site localization was challenging for low-abundance cypher proteoforms, and large proteins such as cMyBP-C (141 kDa) and MHC (223 kDa) were not detected because of MS signal decay with increasing molecular weight, coelution, and limited tissue amounts.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.2006764117

Cites

66 of 70 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. A complex sarcomeric proteoform landscape. (A) Control tissue from left ventricle (LV) of nonfailing donor hearts (Ctrl, n = 16) and HCM tissues procurred via surgical septal myectomy procedure (HCM, n = 16). (B) Schematic representation of cardiac sarcomere, consisting of thin (green) and thick filaments (pink) flanked by Z-disk. (C) Sarcomeric protein interactome showing a complex network of interactions between myofilament and Z-disk proteins. (D) Representative base peak chromatograms showing separation and detection of major sarcomeric proteins by LC-MS for Ctrl and HCM tissues. (E and F) Representative deconvoluted mass spectra showing the proteoforms of (E) myofilament and (F) Z-disk proteins.
Fig. 1. A complex sarcomeric proteoform landscape. (A) Control tissue from left ventricle (LV) of nonfailing donor hearts (Ctrl, n = 16) and HCM tissues procurred via surgical septal myectomy procedure (HCM, n = 16). (B) Schematic representation of cardiac sarcomere, consisting of thin (green) and thick filaments (pink) flanked by Z-disk. (C) Sarcomeric protein interactome showing a complex network of interactions between myofilament and Z-disk proteins. (D) Representative base peak chromatograms showing separation and detection of major sarcomeric proteins by LC-MS for Ctrl and HCM tissues. (E and F) Representative deconvoluted mass spectra showing the proteoforms of (E) myofilament and (F) Z-disk proteins.CC BY-NC-ND · PubMed Central
Fig. 2. Coordinated decrease in cTnI and ENH2 phosphorylation in HCM tissues. Representative deconvoluted mass spectra for (A) cTnI and (B) ENH2 from donor hearts (black) and HCM tissues (red). Mono- and bis-phosphorylation are denoted by red p and pp, respectively. (C) Total protein phosphorylation (Ptot) calculated by mol Pi/mol protein for cTnI and ENH2 in Ctrl (n = 16) and HCM (n = 16). Horizontal bars represent the mean of the group and error bars represent SEM in gray for Ctrl and black for HCM. Groups were considered significantly different at P < 0.05. (D) Localization of cTnI phosphorylation to Ser22/23 and (E) localization of ENH2 phosphorylation to Ser118 by ECD. (F) Linear correlation between cTnI phosphorylation and ENH2 phosphorylation (R2 = 0.9276).
Fig. 2. Coordinated decrease in cTnI and ENH2 phosphorylation in HCM tissues. Representative deconvoluted mass spectra for (A) cTnI and (B) ENH2 from donor hearts (black) and HCM tissues (red). Mono- and bis-phosphorylation are denoted by red p and pp, respectively. (C) Total protein phosphorylation (Ptot) calculated by mol Pi/mol protein for cTnI and ENH2 in Ctrl (n = 16) and HCM (n = 16). Horizontal bars represent the mean of the group and error bars represent SEM in gray for Ctrl and black for HCM. Groups were considered significantly different at P < 0.05. (D) Localization of cTnI phosphorylation to Ser22/23 and (E) localization of ENH2 phosphorylation to Ser118 by ECD. (F) Linear correlation between cTnI phosphorylation and ENH2 phosphorylation (R2 = 0.9276).CC BY-NC-ND · PubMed Central
Fig. 3. Altered phosphorylation of cTnT, Tpm1.1, and MLC-2v. Representative deconvoluted mass spectra from donor hearts (black) and HCM tissues (red) for (A) cTnT, (B) Tpm1.1, and (C) MLC-2v. Monophosphorylation is denoted with red p. Total phosphorylation (Ptot) calculated by mol Pi/mol protein for (D) cTnT, (E) Tpm1.1, and (F) MLC-2v for Ctrl (n = 16) and HCM (n = 16). Horizontal bars represent the mean of the group and error bars represent SEM (gray, Ctrl; black, HCM). Groups were considered statistically different at P < 0.05.
Fig. 3. Altered phosphorylation of cTnT, Tpm1.1, and MLC-2v. Representative deconvoluted mass spectra from donor hearts (black) and HCM tissues (red) for (A) cTnT, (B) Tpm1.1, and (C) MLC-2v. Monophosphorylation is denoted with red p. Total phosphorylation (Ptot) calculated by mol Pi/mol protein for (D) cTnT, (E) Tpm1.1, and (F) MLC-2v for Ctrl (n = 16) and HCM (n = 16). Horizontal bars represent the mean of the group and error bars represent SEM (gray, Ctrl; black, HCM). Groups were considered statistically different at P < 0.05.CC BY-NC-ND · PubMed Central
Fig. 4. Differential tropomyosin isoform expression in HCM. (A) Representative deconvoluted spectra showing Tpm proteoforms Tpm1.2, Tpm1.1, and pTpm1.1 proteoforms. (B) Zoom-in to baseline of deconvoluted mass spectra to show lower abundance Tpm proteoforms, Tpm2.2, Tpm3.12, and pTpm3.12. Monophosphorylation denoted by red p.
Fig. 4. Differential tropomyosin isoform expression in HCM. (A) Representative deconvoluted spectra showing Tpm proteoforms Tpm1.2, Tpm1.1, and pTpm1.1 proteoforms. (B) Zoom-in to baseline of deconvoluted mass spectra to show lower abundance Tpm proteoforms, Tpm2.2, Tpm3.12, and pTpm3.12. Monophosphorylation denoted by red p.CC BY-NC-ND · PubMed Central
Fig. 5. Top-down MS characterization of cypher proteoforms in HCM. Representative deconvoluted mass spectra for (A) cypher-5 and (B) cypher-6 from donor hearts (black) and HCM tissues (red). Sequence tables showing MS/MS cleavages from CAD and ECD for (C) cypher-5 and (D) cypher-6. Mono, bis-, tris, tetra-phosphorylation indicated by red p, pp, 3p, “4p”, respectively. Schematic showing protein backbone cleavages is shown, with fragments produced by CAD and ECD shown in red and blue, respectively.
Fig. 5. Top-down MS characterization of cypher proteoforms in HCM. Representative deconvoluted mass spectra for (A) cypher-5 and (B) cypher-6 from donor hearts (black) and HCM tissues (red). Sequence tables showing MS/MS cleavages from CAD and ECD for (C) cypher-5 and (D) cypher-6. Mono, bis-, tris, tetra-phosphorylation indicated by red p, pp, 3p, “4p”, respectively. Schematic showing protein backbone cleavages is shown, with fragments produced by CAD and ECD shown in red and blue, respectively.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

12 Valid · 0 Not valid · 25 Not checked · 100 Own results and interpretations

64 more claims

Create a free account to see all 137 claims and to verify the 51 references still open.

See all claims — free account
  • Probably not a substantial claim. 46
  • It may state two separate claims as one. 44

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 70 references

Cited by

See all 107

Metadata

Authors
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., Vikhorev, P. G., Marston, S. B., Lal, S., Li, A., dos Remedios, C., Kohmoto, T., Hermsen, J., Ralphe, J. C., Kamp, T. J., Moss, R. L., & Ge, Y.
Affiliations
  • University of Wisconsin–Madison (US)
  • Imperial College London (GB)
  • The University of Sydney (AU)
Corresponding author
Ge, Ying
Venue
Proceedings of the National Academy of Sciences
Published
2020-09-23
Volume
117
Issue
40
Pages
24691-24700
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W3088010440
Cited by
107
References
70
Citations by year
2026: 15 · 2025: 11 · 2024: 24 · 2023: 19 · 2022: 14 · 2021: 22 · 2020: 2
FWCI
8.82
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
  • HHS | NIH | National Heart, Lung, and Blood Institute (R01 HL096971, R01 HL129798, U01 HL134764, HL139883)
  • HHS | NIH | National Institute of General Medical Sciences (T32 GM008505, R01 GM125085, T32 GM008688)
  • HHS | NIH | NIH Office of the Director (S10 OD018475)
  • American Heart Association (17PRE33660224)
  • British Heart Foundation (PG/17/5/32705)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords
hypertrophic cardiomyopathy, post-translational modification, phosphorylation, alternative splicing, myofilament proteins, protein kinase A signaling, septal myectomy, genotype-phenotype correlation, top-down proteomics
MeSH terms
Cardiomyopathy, Hypertrophic, Genotype, Humans, Myocardium, Proteins, Sarcomeres, Mass Spectrometry, Signal Transduction, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics. https://app.cochat.ai/papers/10.1073/pnas.2006764117
The paper
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., Vikhorev, P. G., Marston, S. B., Lal, S., Li, A., dos Remedios, C., Kohmoto, T., Hermsen, J., Ralphe, J. C., Kamp, T. J., . . . Ge, Y. (2020). Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2006764117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.